Bank of New York Mellon »

Kymera Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.8M 122k 47.33
2024-06-30 $4.7M 156k 29.85
2024-03-31 $5.3M 131k 40.20
2023-12-31 $3.4M 134k 25.46
2023-09-30 $1.8M 126k 13.90
2023-06-30 $2.9M 126k 22.99
2023-03-31 $29M 966k 29.63
2022-12-31 $25M 990k 24.96
2022-09-30 $17M 1.0M 16.67
2022-06-30 $20M 1.0M 19.69
2022-03-31 $29M 686k 42.32
2021-12-31 $34M 531k 63.53
2021-09-30 $29M 501k 58.74
2021-06-30 $3.3M 69k 48.47
2021-03-31 $1.5M 38k 38.84
2020-12-31 $2.5M 40k 61.99